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ScienceDirectC-type lectin receptors (CLRs) comprise a large superfamily
of proteins, which recognise a diverse range of ligands, and
are defined by the presence of at least one C-type lectin-like
domain (CTLD). Of particular interest are the single
extracellular CTLD-containing receptors of the ‘Dectin-1’
and ‘Dectin-2’ clusters, which associate with signalling
adaptors or possess integral intracellular signalling
domains. These CLRs have traditionally been associated
with the recognition of fungi, but recent discoveries have
revealed diverse and unexpected functions. In this review,
we describe their newly identified roles in anti-microbial host
defence, homeostasis, autoimmunity, allergy and their
functions in the recognition and response to dead and
cancerous cells.
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Introduction
C-type lectin receptors (CLRs) are normally associated
with carbohydrate binding through conserved motifs
present in the C-type lectin-like domain (CTLD), such
as the EPN motif (which confers binding to mannose, N-
acetylglucosamine, L-fucose, and glucose) and the QPD
motif (which confers recognition of galactose and N-
acetylgalactosamine) [1,2]. Yet CLRs also recognise car-
bohydrates, such as b-glucan, and many non-carbohy-
drate ligands, such as lipids and proteins, through
mechanisms that are not yet fully understood [1,2]. CLRs
are primarily expressed on myeloid cells where they
perform various roles but effectively function as pattern
recognition receptors (PRRs), activating or modulating
immune function upon encountering ligands from ‘non-
self’ (pathogen-associated molecular patterns —
PAMPs), ‘damaged self’ (damage-associated molecular
patterns — DAMPs) or ‘altered self’ (tumour-associated
molecular patterns — TAMPs).www.sciencedirect.com For the purposes of this review, CLRs can be clustered
into two broad groups based on their signalling potential.
Activation receptors transduce intracellular signals via an
integral immunoreceptor tyrosine-based activation
(ITAM)-like motif within their cytoplasmic tails (such
as Dectin-1, Clec-2, and DNGR-1), or via association with
ITAM-bearing FcRg adaptor molecules (such as Dectin-
2, CLECSF8 and Mincle) [3,4] (see Table 1). Activation
of these receptors leads to intracellular signalling through
Syk-dependent and Syk-independent pathways [3], dis-
cussed later. The second group of CLRs possess immu-
noreceptor tyrosine-based inhibition (ITIM)-motif in
their cytoplasmic tails (such as MICL), which recruit
phosphatases including SHP-1, SHP-2 and SHIP upon
receptor activation. Signalling from these receptors gen-
erally supresses cellular activation, including the activity
of activation CLRs [4]. Paradoxically, these inhibitory
receptors can also act to enhance cellular responses in
certain circumstances, by inhibiting inhibitory responses
for example see [5].
Receptors of the ‘Dectin-1’ and ‘Dectin-2’ clusters of
CLRs [6,7] (Figure 1) are of particular interest, and study
of these receptors has provided startling new insights into
the function and roles of CLRs in immunity and homeo-
stasis. In this review, we will focus only on receptors in
these two clusters, discussing the most recent discoveries.
We will cover newly identified functions in host defence
against fungi and bacteria and their emerging roles in
homeostasis, autoimmunity, allergy and recognition of
dead and cancerous cells. The reader is referred to other
recent reviews for more in-depth details on the function
and roles of each of the CLRs discussed here [4,6,7].
CLRs in anti-fungal immunity
Much of the interest in CLRs has emerged from the
discovery that these receptors play critical functions in
anti-fungal immunity [8]. In fact our understanding of
anti-fungal immunity has significantly increased over the
last decade, and we now understand that Th1 effector
cells are critical in anti-fungal immunity, particularly from
systemic infections with pathogens such as Cryptococcus
neoformans [9]. Th17-related immunity, on the other
hand, is also critical, being recently demonstrated to be
essential for protection at the mucosa [10]. Indeed,
defects in several components of the Th17 pathway, from
the signalling molecules (CARD9, STAT1, STAT3) to
the cytokines involved (IL-17) have been linked to
susceptibility to chronic mucocutaneous candidiasis
[11]. CLRs, such as Dectin-1 and Dectin-2, play a central
role in driving the development of these responses [8]. To
date, however, only polymorphisms in Dectin-1 andCurrent Opinion in Immunology 2015, 32:21–27
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Table 1
Alternative names of CLRs discussed in this review
CLR mentioned
in text













Mincle CLEC4E, CLECSF9 CLEC4E/Clec4e
MICL CLEC12A, CLL-1, CLL1,
DCAL-2, KLRL1
CLEC12A/Clec12amutations in signalling molecule CARD9, which acts
downstream of Syk-coupled CLRs (see below), have
been linked to susceptibility to fungal infections in
humans [12,13].
The study of Dectin-1, in particular, has revolutionised
our understanding of host-fungal interactions. This CLR
recognises b-glucans, a carbohydrate present in cell walls
of many, if not all, fungal species, and is required for
immunity to several pathogens including species of Can-
dida, Aspergillus, Pneumocystis and Coccoidiodes [8]. Dectin-
1 was discovered over a decade ago as the first non-Toll-
like receptor capable of coupling microbial recognition
with gene transcription, and there has been much interest
in understanding its intracellular signalling mechanisms
[14]. The activation of Dectin-1 requires receptor clus-
tering into a phagocytic synapse [15], which induces a
signalling pathway now known to be common to all the
activatory CLRs discussed here: tyrosine phosphorylation
of the ITAM-like/ITAM motifs, recruitment and activa-
tion of Syk kinase and subsequent activation of the
CARD9–Bcl10–Malt1 (CBM) scaffold through PKCd
[16]. Stimulation of this pathway by Dectin-1 and otherFigure 1
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Current Opinion in Immunology 2015, 32:21–27 Syk-independent pathways, such as that mediated by
Raf-1, results in the activation of several transcription
factors including NFAT, IRF1, IRF5, and the canonical
and non-canonical subunits of Nf-kb (p65, RelB, c-Rel,
p50 and p52) [6,17–19]. Recently, Dectin-1 activation of
CARD9 was shown to regulate H-Ras activation, through
Ras-GRF-1 phosphorylation, leading to activation of
ERK but not Nf-kb [20] (Figure 2). Dectin-1 mediated
signalling can also be supressed by co-engagement with
other CLRs, such as Mincle, which was found to induce
Mdm2-dependent loss of nuclear IRF1 activity, blocking
Dectin-1 mediated IL12A transcription [19].
Signalling by Dectin-1 regulates numerous cellular
responses including phagocytosis, autophagy, the respira-
tory burst, the production of inflammatory lipids and
numerous cytokines and chemokines including Th17-
polarising cytokines such as IL-23, IL-6 and IL-1b
[8,21]. Dectin-1 induced production of IL-1b is notable,
as it involves both the NLRP3/caspase-1 and non-canon-
ical caspase-8 inflammasomes [17,22,23]. Dectin-1 can
also induce the production of type I interferons (IFNs) in
response to Candida albicans, through IRF5, and was
crucial for protective immunity in mice [24]. Another
group, however, found that these cytokines contributed
to susceptibility to infection with C. glabrata [25]. Impor-
tantly, in humans, there is now evidence that type I IFNs
play a protective role, at least in immunity to C. albicans
[26]. The demonstration that Dectin-1 signalling through
the Raf-1 pathway was able to induce innate memory by
epigenetically reprogramming monocytes is also a signifi-
cant recent advance, with implications for future vaccine
design [27,28].
Other developments in this field involve Dectin-2, a CLR
whose importance in protective anti-fungal immunity has
been clearly demonstrated in animal models [7,29]. Dec-
tin-2 recognises a-mannans from Candida and glycopro-
teins containing O-linked mannobiose-rich residues fromLE 
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 mouse ‘Dectin-1’ and ‘Dectin-2’ clusters. ‘Dectin-1’ cluster is in the
) and the corresponding region in the mouse is in chromosome 6
K gene complex. Linkage, relative size and orientation of the genes
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Schematic representation of selected signal networks induced by various CLRs of the ‘Dectin-1’ and ‘Dectin-2’ clusters. Sensing of microbes by
activatory CLRs such as Dectin-1, Dectin-2, Mincle and MCL mediate inflammation and immunity or antigen cross-presentation through activation
of Syk-dependent and Syk-independent pathways (like the one mediated by Raf-1). Downstream signals from Syk leads to production of ROS and
transcription factor activation by CARD9–Bcl-10–Malt-1 and more recently, CARD9–H-Ras–Ras-GRF1 complex. In some instances, activation of
Syk by activatory CLRs like Dectin-1 can attenuate inflammatory signals by activating protein tyrosine phosphatases (PTP: SHIP, SHP-1 and SHP-
2), which are recruited to inhibitory receptors such as MICL and FcgRIIB. Signals emanating from specific CLRs are depicted: Dectin-1 (green
arrows), Dectin-2 (blue arrows) and Mincle (dashed black arrows). Question marks depict unknown or unclear pathways.Malassezia [7,30]. Signalling from Dectin-2 induces sev-
eral responses including the production of cytokines and
chemokines [7]. Dectin-2 promotes Th17-biased immu-
nity in response to fungi through the differential activa-
tion of cRel containing NF-kb dimers by Malt1, and the
preferential induction of IL-23p19 and IL-1b but not IL-
12p40 [17]. It is likely that simultaneous engagement
with other PRRs is required for amplification of such
responses and the recent description of a Dectin-2/
CLECSF8 heterodimer with enhanced sensitivity to a-
mannans on C. albicans supports this notion [31]www.sciencedirect.com (Figure 2). Dectin-2 signalling also augments IL-17RC
expression in neutrophils, and is involved in an autocrine
IL-17A-IL-17RC feedback loop that is important for ROS
production and fungal elimination [32].
CLRs in anti-mycobacterial immunity
In addition to fungi, there is increasing realisation that
CLRs play a key role in defence against bacterial infec-
tion. CLRs have been implicated in the recognition of
several bacterial pathogens [16], but most interest has
focused on their role in anti-mycobacterial immunity.Current Opinion in Immunology 2015, 32:21–27
24 Innate immunityIndeed, several CLRs recognise mycobacteria including
Dectin-1, Mincle and most recently CLECSF8 and Dec-
tin-2 [33–35]. In fact, the activity of Complete Freund’s
Adjuvant (CFA), a mycobacterial-based adjuvant widely
used in experimental models, was shown to require
signalling through Mincle [36]. CLECSF8, like Mincle,
recognises mycobacterial cord factor (trehalose dimyco-
late, TDM) driving pro-inflammatory innate responses
and the development of Th17 immunity [33,34].
CLECSF8 was also required for induction of Mincle
following TDM stimulation [34], leading to the formation
of functional heterodimers [37].
Dectin-2 recognises mannose-capped lipoarabinomannan
(Man-LAM) and like the other CLRs, induces cytokine
production and induction of Th17 responses [35]. Despite
the ability of all these CLRs to recognise and respond to
mycobacterial components the role of these receptors
during infection is still unclear. Most appear redundant
or show limited defects during infection, and no links
with human disease have yet been described [33,35,38–
40]. The substantially increased susceptibility of CARD9
knockout mice to mycobacterial infection [41], however,
shows that signalling from these receptors is required for
protection. Presumably these CLRs are able to compen-
sate for each other during infection.
CLRs in homeostasis, autoimmunity and
allergy
Like many other PRRs, there is increasing evidence that
CLRs can regulate immune homeostasis, autoimmunity
and allergy. For example, treatment of mice with the
Dectin-1 ligand, b-glucan, provides protection from type-
1 diabetes but can also induce arthritis in susceptible mice
[42,43]. Dectin-1 can inhibit inflammation induced by the
complement component, C5a, in the presence of glyco-
sylated IgG1–immune complexes. This mechanism
involves Syk-mediated phosphorylation of FcgRIIB
and the subsequent activation of Src homology 2 do-
main-containing inositol phosphatase (SHIP) [44]. Another
recent example is Clec-2, which recognises podoplanin,
and interactions with this ligand are required for DC
motility along stromal surfaces and for the development
of lymphatic vasculature and lymph nodes [45–48].
There is growing literature on the importance of these
CLRs in immune homeostasis of the gastrointestinal
tract. Dectin-1 is essential for facilitating the reverse
transcytosis of secretory IgA complexes by intestinal
microfold (M) cells [49] and is involved in promoting
tolerogenic signals in response to mucus [50]. The
sensing of mucus (specifically MUC2) in the small intes-
tines involves a complex of galectin-3, Dectin-1 and
FcgRIIB on antigen-sampling dendritic cells which acti-
vates b-catenin and inhibits NF-kb-mediated pro-inflam-
matory gene expression [50]. The ability of Dectin-1 to
sense mycobiota is also important for gut homeostasis, asCurrent Opinion in Immunology 2015, 32:21–27 loss of this receptor leads to fungal-mediated exacerbation
of inflammation in murine models of colitis [51]. More-
over, polymorphisms of Dectin-1 were found in patients
with severe ulcerative colitis, suggesting that anti-fungals
could be used to treat these individuals [51].
CLRs also initiate and modulate allergic responses. Dec-
tin-1, for example, promotes immunopathology during
fungal allergy [52]. Most interest, however, has focussed
on Dectin-2, which induces cysteinyl leukotriene produc-
tion in response to HDM [53]. The production of these
lipid mediators, as well as IL-33, is essential for the
initiation of airway inflammation and promotion of sub-
sequent Th2 immunity in response to HDM [53–56]. In
murine models, Dectin-2 is involved in the development
of allergic responses to HDM during both the sensitisa-
tion and challenge stages [57,58].
CLRs in the recognition of dead cells and
tumours
CLRs, including Mincle, DNGR-1 and MICL, can sense
cell death [59]. Mincle was the first such receptor identi-
fied, and shown to induce pro-inflammatory responses
after sensing SAP130 released from dead cells [60]. This
ability to detect and respond to dead cells has recently
been linked to pathogenic responses induced after ischae-
mic stroke and traumatic brain injury [61,62].
DNGR-1 is expressed by specific subsets of DCs and
recognises F-actin exposed on necrotic cells [63,64,65].
Although this receptor possesses an ITAM-like motif in
its cytoplasmic tail, it does not induce pro-inflammatory
responses [64]. Rather, signalling from this receptor is
required for antigen cross-presentation [66]. The mech-
anisms involved are incompletely understood, but essen-
tial for antiviral immunity [67,68].
Myeloid inhibitory C-type lectin-like receptor (MICL,
CLEC12A, CLL-1) is the newest ‘kid’ on the block and
recognises uric acid and proteinaceous ligand(s) on ne-
crotic cells [69]. MICL functions as an inhibitory recep-
tor, blocking signalling from Syk-coupled activation
receptors, and loss of this CLR results in hyperinflamma-
tion in the presence of cellular necrosis [69]. MICL is
also highly expressed on most acute myeloid leukaemias
and, although its function on these cells is unknown, it has
been suggested to be a useful marker of this disease [70].
CLRs have long been associated with immunity to can-
cer, particularly those receptors expressed on NK cells
and involved in the recognition of MHC molecules. Very
recently, Dectin-1 has been implicated in NK-mediated
killing of tumour cells [71]. Here, Dectin-1 expressed
on DCs and macrophages was shown to recognise N-
glycans present on the surface of tumour cells, triggering
IRF5 nuclear translocation and induction of several genes
including Inam, known to enhance tumour killing by NKwww.sciencedirect.com
C-type lectins Dambuza and Brown 25cells through homophilic interactions [71]. More work is
required to determine the nature of the ligands involved,
and how they interact with Dectin-1. Nevertheless, these
observations have exciting clinical implications and may
explain, at least in part, the anti-tumour activities of b-
glucans [72]. It is tempting to speculate that other CLRs
in the ‘Dectin-1’ and ‘Dectin-2’ clusters may similarly be
involved in such responses.
Concluding remarks
Recent data on the ‘Dectin-1’ and ‘Dectin-2’ cluster of
CLRs have provided astonishing new insights into their
roles and functions in immunity and homeostasis. These
receptors, which are conserved in all chordates [73], are
able to trigger numerous cellular and immunological
responses critical for the control and regulation of infec-
tion, homeostasis, autoimmunity, allergy and cancer.
CLRs offer tremendous potential to enhance the efficacy
of vaccines and as therapeutic targets in infectious and
non-infectious diseases. Yet, we are only beginning the
voyage of discovery and there is much we still need to
understand. Critical questions remain, such as under-
standing how CLR responses are negatively regulated
(this is almost completely unstudied), understanding how
responses from multiple CLRs and other PRRs are inte-
grated, and understanding how polymorphisms and muta-
tions in CLRs contribute to human disease.
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